EU Committees Back Rules on GM Microbes, Organs
Environment and public health committees approved a draft position on genetically modified micro-organisms and transplant organ processing.
Updated on Nov. 10, 2026 in Life Sciences
European Parliament committees approved their position on EU rules for genetically modified micro-organisms (GMMs) and the processing of transplant organs, by 54 votes to 18, with 16 abstentions. The full Parliament must still vote on the draft report, possibly in December.
Why it matters
The rules aim to boost research and innovation in the EU without lowering environmental and safety standards. The proposals would tighten oversight of organ processing while keeping organ donation voluntary and unpaid.
The committees approved the position by 54 votes to 18, with 16 abstentions, after adopting 20 compromise amendments negotiated between political groups. Open-ended authorisation of GMMs could be granted only at the first renewal, after an initial 10-year period, and the full plenary vote remains pending.
The players
Marta Temido
Marta Temido is a Portuguese politician and Member of the European Parliament who co-authored the draft report on GMMs and organ processing.
Adam Jarubas
Adam Jarubas is a Polish politician and Member of the European Parliament who co-authored the draft report on GMMs and organ processing.
European Parliament
The European Parliament is the directly elected legislative body of the European Union, which must still vote on the draft report.
The details
The draft report by MEPs Marta Temido and Adam Jarubas rejects amendments that would have let Member States restrict or prohibit the release of authorised GMMs, while allowing certain GMMs to be approved through an expedited procedure. For organ processing, transplant centres would need prior authorisation from the competent authority, and an EU alert system for serious adverse events is proposed.
Timeline
10 November 2026: Environment and public health committees approved the position on GMM and organ rules.
December 2026: The full European Parliament may hold its plenary vote on the draft report.
The Big Picture
The proposal extends the EU's existing genetically modified organism framework to micro-organisms, while adding an expedited approval path for certain GMMs that the EU's standard release rules do not provide. It signals an effort to speed biotechnology research without departing from the bloc's environmental and safety standards.
If adopted, the rules would set how quickly certain GMMs can reach the market and how long open-ended authorisations last, affecting research labs and biotech firms working in the EU. Transplant centres would need prior authorisation to process organs, and donation would remain voluntary and unpaid.
The takeaway
Researchers and transplant professionals should track the December plenary vote, since the final text will determine approval timelines and oversight duties. Readers interested in organ donation can note that the rules keep donation voluntary and prohibit sales.
What happens next
The full European Parliament is expected to hold a plenary vote on the draft report, possibly in December 2026.
Further reading
For related coverage, explore more in Life Sciences.
More information
Read the compromise amendments text for GMMs and organs directly from the European Parliament's documentation.
